We serve Chemical Name:3-heptyl-1,2-bis(9-isocyanatononyl)-4-pentylcyclohexane CAS:68239-06-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-heptyl-1,2-bis(9-isocyanatononyl)-4-pentylcyclohexane
CAS.NO:68239-06-5
Synonyms:EINECS 269-419-6;2-Heptyl-3,4-bis(9-isocyanatononyl)-1-pentylcyclohexane;Cyclohexane,2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentyl
Molecular Formula:C38H70N2O2
Molecular Weight:586.97500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:642.6ºC at 760 mmHg
Density:0.95g/cm3
Index of Refraction:1.503
PSA:58.86000
Exact Mass:586.54400
LogP:12.09900
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like EINECS 269-419-6 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclohexane,2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclohexane,2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentyl Use and application,EINECS 269-419-6 technical grade,usp/ep/jp grade.
Related News: Improved gene mining techniques have permitted previously uncharacterized gene clusters to be discovered, while advances in heterologous expression and production have allowed the encoded enzymes to rapidly be scaled up and evaluated as tools for organic synthesis. 2-(2,2-dimethyl-5-oxopyrrolidin-1-yl)-N-(2-((2R,6S)-2,6-dimethylpiperidin-1-yl)ethyl)acetamide manufacturers Charles River Ballina, through the Corporate Citizenship programme, has continued to support worthwhile causes in the local community and has funded a number of organizations, including the Mayo Roscommon Hospice, the River Moy Search & Rescue and the Ballina Community Clean Up Volunteer Organisation who have helped develop a local sensory garden. 3,3′-(Hexamethylendinitrilo)-di-1-butanol suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. Cyclo[D-alanyl-L-tyrosyl-L-valyl-(4R)-4-hydroxy-L-prolyl-D-allothreonyl-L-threonyl-(3S)-3-hydroxy-L-prolyl-(3R)-3-hydroxy-L-glutaminylglycyl-D-allothreonyl-N5,N5-di-2-propenyl-L-ornithyl-(3R)-3-hydroxyhexadecanoyl-D-allothreonyl], monohydrochloride vendor & factory.
